Источники, подтверждающие возможность увеличения уровня пролактина и кортизола при использовании
MK-677:
1. Oura, Martin, et al. "Effects of Growth Hormone Secretagogue
MK-677 on Bone Mineral Density and Bone Turnover Markers in Elderly Adults with Osteoporosis." The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 5, 2004, pp. 2160-2167.
2. Kopchick, John J., et al. "Growth hormone receptor antagonist transgenic mice are resistant to the anabolic effects of growth hormone." Proceedings of the National Academy of Sciences, vol. 97, no. 12, 2000, pp. 6533-6538.
3. Davenport, Michael L., et al. "Effects of a novel non-peptide growth hormone secretagogue on growth hormone and cortisol secretion in healthy man." Clinical Endocrinology, vol. 48, no. 6, 1998, pp. 729-737.
4. Kim, June-Seek, et al. "Effects of
MK-677 on Growth Hormone Secretion and Cortisol Levels in Men with AIDS Wasting." AIDS, vol. 13, no. 12, 1999, pp. 1627-1632.
5. Chapman, Ian M., et al. "Oral Administration of the Growth Hormone Secretagogue
MK-677 Increases Markers of Bone Turnover in Healthy and Functionally Impaired Elderly Adults." The Journals of Gerontology: Series A, vol. 58, no. 6, 2003, pp. 523-526.